Selegiline recalls

The FDA has published 2 recalls involving Selegiline since 2014. The latest was reported on 14 Sep 2016. Most were for labeling errors. Stason Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 14 Sep 2016

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 1 50%Class III 1 50%

Why selegiline is recalled

Labeling Errors150%
Potency & Assay150%

Companies

Stason Pharmaceuticals150%
Aidapak Services150%

By year

2016150%
2014150%

All selegiline recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
14 Sep 2016Drug	CLASS III	Selegiline HCL Tablets USP 5mg recalled by Stason Pharmaceuticals	Stason Pharmaceuticals	Potency & Assay	NC
22 Jan 2014Drug	CLASS II	Selegiline HCL, Capsule, 5 mg recalled by Aidapak Services	Aidapak Services	Labeling Errors	4 states

Should you stop taking Selegiline?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.